Mahindra Manulife Value Fund
The scheme seeks to generate long-term capital appreciation from a diversified portfolio of predominantly equity and equity related instruments of companies which are undervalued (or are trading below their intrinsic value).
Growthvine rating: 2/5 — ranked #15 of 25 in category.
Fund basics
| Category | Equity: Value |
|---|
| NAV | ₹11.36 (as of 2026-10-23) |
|---|
| AUM | ₹1,015 Cr |
|---|
| Expense ratio | 1.92% |
|---|
| Riskometer | Very High |
|---|
| Fund manager | Krishna Sanghavi |
|---|
| Exit load | 0.5% for redemption within 3 months |
|---|
Performance & risk
| Standard deviation | 0.00% |
|---|
| Max drawdown | −11.69% |
|---|
| Alpha | 0 |
|---|
| Beta | 0 |
|---|
Over 5 years, captured 112.0% of Nifty 500's upside and 79.9% of its downside.
Market cap allocation
| Large cap | 49.1% |
|---|
| Mid cap | 21.9% |
|---|
| Small cap | 28.9% |
|---|
Concentration
| Top 5 holdings | 17.6% |
|---|
| Top 10 holdings | 29.0% |
|---|
| Total holdings | 68 |
|---|
| Index overlap | 27.6% |
|---|
| Active share | 72.4% |
|---|
Top holdings
- Reliance Industries Ltd — 4.1%
- HDFC Bank Ltd. — 3.6%
- AXIS Bank Ltd. — 3.6%
- ICICI Bank Ltd. — 3.6%
- LIFE INSURANCE CORPORATION OF INDIA — 2.7%
- Adani Enterprises Ltd. — 2.4%
- Jindal Saw Ltd. — 2.4%
- Oil India Limited — 2.3%
- VODAFONE IDEA LIMITED — 2.2%
- Bandhan Bank Limited — 2.1%
Top sectors
- Banking & Financial — 19.8%
- Industrial Products — 8.7%
- Pharma & Biotech — 8.4%
Calendar-year track record
| Year | Return | Quartile | Category rank |
|---|
| 2026 (partial) | −5.3% | Q2 | #7 of 23 |